Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Ming Lei | Researchclopedia

Back to researchers

Ming Lei

Central South University ORCID

105

Works

7,563

Citations

26

h-index

47

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Gastric Cancer Management and Outcomes Esophageal Cancer Research and Treatment

Affiliations

Parsons (United States)2024–2024

Central South University2018–2025

Guiyang Medical University2008–2008

Inserm2021–2021

China National Nuclear Corporation2025–2025

Top Works

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian,Kohei Shitara,et al.

20212,789 citations

Cancer-related molecular mechanisms research

Pancreatic and Hepatic Oncology Research

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly,Jaffer A. Ajani,et al.

20211,684 citations

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Yuichiro� Doki,Jaffer A. Ajani,et al.

2022532 citations

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

Kohei Shitara,Jaffer A. Ajani,et al.

2022425 citations

Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Thierry André,Sara Lonardi,et al.

2022239 citations

LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study

Markus Moehler,Kohei Shitara,et al.

2020202 citations

Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer

Thierry André,Elena Élez,et al.

2024171 citations

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial

Thierry André,Elena Élez,et al.

2025132 citations

Regulatory role of calpain in neuronal death

Kun Xiong,Siying Cheng,et al.

201890 citations